Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Marken unveils new solution for clinical trials management
According to the company, Solo helps in the management of its global depot network including receipt of clinical supplies and kits, dispatches, returns, warehouse movements and QA releases.
According to the company, Solo helps in the management of its global depot network including receipt of clinical supplies and kits, dispatches, returns, warehouse movements and QA releases.
The center will support the development and commercialization of cell therapies and advanced therapeutics, as well as the technologies for manufacturing, quality control, safety and efficiency. The Technology
The agreement provides OvaGene with worldwide rights to develop and commercialize proprietary microRNA-based assays that predict drug response for currently used cancer treating drugs. The proprietary assays were
The new division, ArjoHuntleigh Home Care, is believed to provide a broad range of product solutions that aid in patient handling systems, hygiene systems, therapeutic surfaces, medical beds,
According to the company, it has set up a distribution center where independent distributors can pick up products. Herbalife is known for its products like Formula 1 Nutritional
The findings of the research have been published in the Journal of the American Dietetic Association. The research was led by assistant professor Olivia Phung, who intended to
The move by the agency will authorize the sale of product in the Canadian market. Omazen is EPA:DHA fatty acid formulation, which elevates Omega-3 fatty acid levels and
Following the deal, the company will develop new drugs with its manufacturing technique of pharmaceutical products and hopes to strengthen domestic sales in Bangladesh. On completion of the
Cobicistat, a quad single-tablet regimen is a potent mechanism-based inhibitor of cytochrome P450 3A (CYP3A), an enzyme that metabolizes drugs in the body. The Study 114 is a
The deal provides additional intellectual property to protect Zertane ODT formulation, that allows for rapid oral absorption, without the need for liquids. The acquisition of the drug delivery